Effect of disease severity and dopaminergic medication on recollection and familiarity in patients with idiopathic nondementing Parkinson's

Neuropsychologia

Volumn 48, Issue 5, 2010, Pages 1367-1375

  Edelstyn, Nicola M J ^a   Shepherd, Tom A ^a   Mayes, Andrew R ^b   Sherman, Susan M ^a   Ellis, Simon J ^c  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

Disease severity; Dopaminergic medication; Familiarity; Parkinson's disease; Recollection

Indexed keywords

CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG CLASSIFICATION; EPISODIC MEMORY; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; RECALL; TEMPORAL CORTEX;

AGED; DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; RECOGNITION (PSYCHOLOGY); SEVERITY OF ILLNESS INDEX;

EID: 77949773081     PISSN: 00283932     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2009.12.039     Document Type: Article

References (82)

1. Aggleton J.P., Brown M.W. Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behavioural and Brain Sciences 1999, 122:425-489.
2. Aggleton J.P., Brown M.W. Interleaving brain systems for episodic and recognition memory. Trends in Cognitive Science 2006, 10:455-463.
3. Aggleton J.P., Vann S.D., Denby C., Dix S., Mayes A.R., Roberts N., et al. Sparing of the familiarity component of recognition memory in a patient with hippocampal pathology. Neuropsychologia 2005, 43:1810-1823.
4. Baayen R.H., Piepenbrock R., van Rijn H. The CELEX lexical database (CD-ROM) 1993, University of Pennsylvania, Linguistic Data Consortium, Philadelphia, PA.
5. Barnes J., Boubert L., Harris J., Lee A., David A.S. Reality monitoring and visual hallucinations in Parkinson's disease. Neuropsychologia 2003, 41(5):565-574.
6. Bastin C., Van der Linden M., Charnallet A., Denby C., Montaldi D., Roberts N., et al. Dissociation between recall and recognition memory performance in an amnesic patient with hippocampal damage following carbon monoxide poisoning. Neurocase 2004, 10:330-344.
7. Bentivoglio M., Morelli M. Dopamine circuits and receptors. Handbook of chemical neuroanatomy 2005, Vol. 21. Elsevier.
8. Beyer M.K., Apostolova L.G., Green A.E., Hwang K.S., Morra J.S., Chou Y-Y., et al. Automated 3D mapping of hippocampal and caudate atrophy and ventricular enlargement in Parkinson's disease with and without dementia. Movement Disorders 2009, 24(Suppl. 1):S291.
9. Bouchard T.P., Malykhin N., Martin W.R.W., Hanstock C.C., Emery D.J., Fisher N.J., et al. Age and dementia-associated atrophy predominates in the hippocampal head and amygdale in Parkinson's disease. Neurobiology of Aging 2008, 29(7):1027-1039.
10. Bowles B., Crupi C., Mirattari S.M., Pigott S.E., Parrent A.G., Pruessner J.C., et al. Impaired familiarity with preserved recollection after anterior temporal-lobe resection that spares the hippocampus. Proceedings of the National Academy of Sciences 2007, 104(41):16382-16387.
11. Braak H., Del Tredici K. Reply to " Controversies over the staging of α-synuclein pathology in Parkinson's disease" Acta Neuropathology 2008, 116:129-131.
12. Braak H., Del Tredici K., Rüb U., de Vos R.A.I., Jansen Steur E.N.H., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging 2003, 24:197-211.
13. Braak H., Rüb U., Del Tredici K. Cognitive decline correlates with neuropathological stage in Parkinson's disease. Journal of Neurological Sciences 2006, 248:255-258.
14. Brück A., Kurki T., Kaasinen V., Vahlberg T., Rinne J.O. Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment. Journal of Neurology, Neurosurgery and Psychiatry 2004, 75:1467-1469.
15. Bunzeck N., Schütze H., Stallforth S., Kaufmann J., Düzel S., Heinze H.-J., et al. Mesolimbic novelty processing in older adults. Cerebral Cortex 2007, 17:2940-2948.
16. Burton E.J., McKeith I.G., Burn D.J., Williams E.D., O'Brien J.T. Cerebral atrophy in Parkinson's disease with and without dementia: A comparison with Alzheimer's disease, dementia with Lewy bodies and conreols. Brain 2004, 127:791-800.
17. Camicoli R., Moore M.M., Kinney A., Corbridge E., Glassberg K., Kaye J.A. Parkinson's disease is associated with hippocampal atrophy. Movement Disorders 2003, 18(7):784-790.
18. Camicioli R., Moore M.M., Kerr D., Kaye J. Dementia in Parkinson's disease is associated with hippocampal atrophy. Neurology 1999, 52:A486.
19. Coltheart M. The MRC Psycholinguistic Database. Quarterly Journal of Experimental Psychology 1981, 33A:497-505.
20. Cools R. Dopaminergic modulation of cognitive function implications for L-DOPA treatment in Parkinson's disease. Neuroscience and Biobehavioral Reviews 2006, 30(1):1-23.
21. Cools R., Altamirano L., D'Esposito M. Reversal learning in Parkinson's disease depends on medication status and outcome valence. Neuropsychologia 2006, 44:1663-1673.
22. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cerebral Cortex 2001, 11(12):1136-1143.
23. Costa A., Peppe A., Dell'Agnello G., Caltagirone C., Carlesimo G.A. Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: Effects of pramipexole and pergolide on working memory. Neuropsychologia 2009, 47:1374-1381.
24. Cummings D.M., Milnerwood A.J., Dallérac G.M., Waights V., Brown J.Y., Vatsavayai S.C., et al. Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntingdon's disease. Human Molecular Genetics 2006, 15(19):2856-2868.
25. Dashtipour K., Zarifi M., Hakimi A., Demattos N.V., Sadiqua N., Obenaus A. Hippocampal volumes in patients with Parkinson's disease. Movement Disorders 2009, 24:S186.
26. Daum I., Schugens M.M., Spieker S., Poser U., Schonle P.W., Birbaumer N. Memory and skill acquisition in Parkinson's disease and frontal lobe dysfunction. Cortex 1995, 31:413-432.
27. Davidson P.S.R., Anaki D., Saint-Cyr J.A., Chow T.W., Moscovitch M. Exploring the recognition memory deficit in Parkinson's disease: Estimates of recollection versus familiarity. Brain 2006, 129:1768-1779.
28. Dodd M.L., Klos K.J., Bower J.H., Geda Y.E., Josephs K.A., Ahlskog J.E. Pathological gambling caused by drugs used to treat Parkinson's disease. Archives of Neurology 2005, 62:1377-1381.
29. Driver-Dunckley E., Samanta J., Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 2003, 61:422-423.
30. Duda J.E., Noorigian J.V., Weintraub D., Moberg P.J., Davatzikos C., Deepthi K., et al. Cognitive impairment in subjects with Parkinson's disease is associated with hippocampal atrophy and ventricular enlargement. Movement Disorders 2009, 24(Suppl. 1):S296.
31. Dunn J.C. Remember-know: A matter of confidence. Psychological Review 2004, 111:524-542.
32. Düzel S., Schütze H., Stallforth S., Kaufmann J., Bodammer N., Bunzeck N., et al. A close relationship between verbal memory and SN/VTA integrity in young and older adults. Neuropsychologia 2008, 46:3042-3052.
33. Edelstyn N.M.J., Mayes A.R., Condon L., Tunnicliffe M., Ellis S.J. Recognition, recollection, familiarity and executive function in patients with moderate Parkinson's Disease. Journal of Neuropsychology 2007, 1:131-147.
34. Eichenbaum H, Yonelinas A.P., Ranganath C. The medial temporal lobe and recognition memory. Annual Review of Neuroscience 2007, 30:123-152.
35. Fahn S., Elton R.L. The Unified Parkinson's Disease Rating Scale. Recent developments in Parkinson's disease 1987, 293-304. Macmillan, Florham Park, NJ. S. Fahn, C.D. Marsden, D.B. Calne, M. Goldstein (Eds.).
36. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatry Research 1975, 12:189-198.
37. Gabrieli J.D.E., Singh J., Stebbins G.T., Goetz C.G. Reduced working memory span in Parkinson's disease: Evidence for the role of a frontostriatal system in working and strategic memory. Neuropsychology 1996, 10(3):322-332.
38. Garey L.J. Brodmann's 'localisation in the cerebral cortex' 1999, Imperial College Press, London.
39. Gotham A.M., Brown R.G., Marsden C.D. 'Frontal' cognitive function in patients with Parkinson's disease 'ON' and 'OFF' levodopa. Brain 1988, 111:299-321.
40. Hay J.F., Moscovitch M., Levine B. Dissociating habit and recollection: Evidence from Parkinson's disease, amnesia and focal lesion patients. Neuropsychologia 2002, 40:1324-1334.
41. Hoehn M.M., Yahr M.D. Parkinsonism: Onset, progression and mortality. Neurology 1967, 17:427-442.
42. Ibarretxe-Bilbao N., Ramírez-Ruiz B., Tolosa E., Martí M.J., Valldeoriola F., Bargalló N., et al. Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia. Journal of Neurology 2008, 255:1324-1331.
43. Ivory S.J., Knight R.G., Longmore B.E., Cardoc-Davies T. Verbal memory in nondemented patients with idiopathic Parkinson's disease. Neuropsychologia 1999, 37(7):817-828.
44. Jokinen P., Bruck A., Aalto S., Forsback S., Parkkola R., Rinne J.O. Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Related Disorders 2009, 15:88-93.
45. Johnson M.A., Pollard C.C., Vernon P.A., Tomes J.L., Jog M.S. Memory perception and strategy use in Parkinson's disease. Parkinsonism and Related Disorders 2005, 11:111-115.
46. Kalaitzakis M.E., Graeber M.B., Gentleman S.M., Pearce R.K.B. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: A critical analysis of α-synuclein staging. Neuropathology and Applied Neurobiology 2008, 34:284-295.
47. Kumaran D., Düzel E. The hippocampus and dopaminergic midbrain: Old couple, new insights. Neuron 2008, 60:197-200.
48. Laakso M.P., Partanen K., Riekkinen P., Lehtovitra M., Helkala E.L., Hallikainen M., et al. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia and in vascular dementia: An MRI study. Neurology 1996, 46:678-681.
49. Lemon N., Manahan-Vaughan D. Dopamine D1/D5 receptors gate the acquisition of novel information through hippocampus long-term potentiation and long-term depression. Journal of Neuroscience 2006, 26:7723-7729.
50. Li S., Cullen W.K., Anwyl R., Rowan M.J. Dopamine-dependent facilitation of LTP induction in hippocampal CA1 by exposure to spatial novelty. Nature Neuroscience 2003, 6:526-531.
51. Liljequist R., Haapalinna A., Ahlander M., Li Y.H., Mannisto P.T. Catechol O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats. Behavioral Brain Research 1997, 82:195-202.
52. MacDonald S.W.S., Cervenka S., Farde L., Nyberg L., Bäckman L. Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning. Neuropsychologia 2009, 47:2299-2304.
53. Martins de Lima M.N., Laranja D.C., Caldana F., Grazziotin M.M., Garcia V.A., Dal-Pizzol F., et al. Selegiline protects against recognition memory impairment induced by neonatal iron treatment. Experimental Neurology 2005, 169(1):177-183.
54. Mayes A.R., Holdstock J.S., Isaac C.L., Hunkin N.M., Roberts N. Relative sparing of item recognition memory in a patient with adult-onset damage limited to the hippocampus. Hippocampus 2002, 12(3):325-340.
55. Mayes A.R., Holdstock J.S., Isaac C.L., Montaldi D., Grigor J., Gummer A., et al. Associative recognition in a patient with selective hippocampal lesions and relatively normal item recognition. Hippocampus 2004, 14:763-784.
56. Mayes A.R., Montaldi D., Migo E. Associative memory and the medial temporal lobes. Trends in Cognitive Sciences 2007, 11(3):126-135.
57. Mockett B.G., Brooks W.M., Tate W.P., Abraham W.C. Dopamine D1/D5 receptor activation fails to initiate an activity-independent late-phase LTP in rat hippocampus. Brain Research 2004, 1021:92-100.
58. 5 receptor activation reverses NMDA receptor-dependent long-term depression in rat hippocampus. The Journal of Neuroscience 2007, 27(11):2918-2926.
59. Montaldi D., Spencer T.J., Roberts N., Mayes A.R. The neural system that mediates familiarity memory. Hippocampus 2006, 16(5):504-520.
60. Nelson H.E., Willison J. National Adult Reading Test 1991, NFER-Nelson, Windsor, Berks.
61. O'Carroll C.M., Martin S.J., Sandin J., Frenguelli B., Morris R.G.M. Dopaminergic modulation of the persistence of one-trial hippocampus-dependent memory. Learning and Memory 2006, 13:760-769.
62. Otmakhova N.A., Lisman J.E. D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses. Journal of Neuroscience 1996, 16:7478-7486.
63. Reynolds W.M., Kobak K.A. Hamilton Depression Inventory: A self-report version of the Hamilton Depression Rating Scale 1995, Psychological Assessment Resources, Odessa, FL.
64. Roth M., Huppert F.A., Mountjoy C.Q., Tym E. CAMDEX-R: The Cambridge examination for mental disorders of the elderly-Revised 1998, Cambridge University Press, Cambridge.
65. Rowe J.B., Hughes L., Ghosh B.C.P., Eckstein D., Williams-Gray C.H., Fallon S., et al. Parkinson's disease and dopaminergic therapy: Differential effects on movement, reward and cognition. Brain 2008, 131:2094-2105.
66. Schott B.H., Seidenbecher C.I., Fenker D.B., Lauer C.J., Bunzeck N., Bernstein H.G., et al. The dopaminergic midbrain participates in human episodic memory formation: Evidence from genetic imaging. Journal of Neuroscience 2006, 26:1407-1417.
67. Schott B.H, Sellner J., Lauer C.J., Habib R., Frey J.U., Guderian S., et al. Activation of midbrain structures by associative novelty and the formation of explicit memory in humans. Learning and Memory 2004, 11:383-387.
68. Shimamura A.P., Janowsky J.S., Squire L.R. What is the role of frontal lobe damage in memory disorders?. Frontal lobe function and dysfunction 1991, 173-195. Oxford University Press, New York. H.S. Levin, H.M. Eisenberg, A.L. Benton (Eds.).
69. Snodgrass J.G., Corwin J. Pragmatics of measuring recognition memory. Applications to dementia and amnesia. Journal of Experimental Psychology (General) 1988, 117:34-50.
70. Taylor K., Probst A. Anatomic localization of the transentorhinal region of the perirhinal cortex. Neurobiology of Aging 2008, 29(10):1591-1596.
71. Tsivilis D., Vann S.D., Denby C., Roberts N., Mayes A.R., Montaldi D., et al. A disproportionate role for the fornix and mamillary bodies in recall versus recognition memory. Nature Neuroscience 2008, 11(7):834-842.
72. Vann S.D., Tsivilis D., Denby C.E., Quamme J.R., Yonelinas A.P., Aggleton J.P., et al. Impaired recollection but spared familiarity in patients with extended hippocampal system damage revealed by three convergent methods. Proceedings of the National Academy of Science 2009, 106:5442-5447.
73. Van Hoesen G.W., Pandya D.N. Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. III. Efferent connections. Brain Research 1975, 95(1):39-59.
74. Vargha-Khadem F., Gadian D.G., Watkins K.E., Connelly A., Van Paesschen W., Mishkin M. Differential effects of early hippocampal pathology on episodic and semantic memory. Science 1997, 277:376-380.
75. Wittman B.C., Schiltz K., Boehler C.N., Düzel E. Mesolimbic interaction of emotional valence and reward improves memory formation. Neuropsychologia 2008, 46:1000-1008.
76. Wittman B.C., Schott B.H., Guderian S., Frey J.U., Heinze H., Düzel E. Reward-related fMRI activation of dopaminergic midbrain is associated with enhanced hippocampus-dependent long-term memory formation. Neuron 2005, 45(3):459-467.
77. Wixted J.T. Dual-process theory and signal detection theory of recognition memory. Psychological Review 2007, 114:152-176.
78. Wixted J.T., Stretch V. In defense of the signal detection interpretation of remember/know judgments. Psychonomic Bulletin and Review 2004, 11:616-641.
79. Wood M.A., Kaplan M.P., Park A., Oliveira E.J., Lombardi T.L., Abel T. Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage. Learning and Memory 2006, 13:609-617.
80. Yonelinas A.P., Jacoby L.L. The relation between remembering and knowing as bases for recognition: Effects of size congruency. Journal of Memory and Language 1995, 34:622-643.
81. Yonelinas A.P., Kroll N.E., Quamme J.R., Lazzara M.M., Suauve M.J., Widaman K.F., et al. Effects of extensive temporal lobe damage or mild hypoxia on recollection and familiarity. Nature Neuroscience 2002, 5:1236-1241.
82. Yonelinas A.P., Widaman K., Mungas D., Reed B., Weiner M.W., Chui H.C. Memory in the aging brain: Doubly dissociating the contribution of the hippocampus and entorhinal cortex. Hippocampus 2007, 17:1134-1140.